#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	3430	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2361	428.5	0	.	n	.	0	C1450T	SNP	1450	1450	C	1846	1846	T	547	T,C	456,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	3430	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2361	428.5	1	SNP	n	C1184T	0	.	.	1184	1184	C	1580	1580	C	511	C	410	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	3430	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2361	428.5	0	HET	.	.	.	A69G	.	69	69	A	465	465	A	471	A,G	287,104	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5514	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3853	427.8	0	.	n	.	0	G1337A	SNP	1337	1337	G	1844	1844	A	457	A	371	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5514	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3853	427.8	0	.	n	.	0	T1971C	SNP	1971	1971	T	2478	2478	C	533	C,T	422,3	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5514	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3853	427.8	1	SNP	n	A2045G	0	.	.	2045	2045	A	2552	2552	A	535	A,C	427,2	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5514	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3853	427.8	1	SNP	n	C2597T	0	.	.	2597	2597	C	3104	3104	C	509	C,G	414,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_M_01364c	folP.WHO_M_01364c	1	1	539	474	folP	852	852	99.88	folP.l15.c4.ctg.1	2011	70.5	0	.	p	.	0	E151K	NONSYN	451	453	GAA	1045	1047	AAA	113;114;114	A;A;A	90;93;90	.	.
folP.WHO_M_01364c	folP.WHO_M_01364c	1	1	539	474	folP	852	852	99.88	folP.l15.c4.ctg.1	2011	70.5	1	SNP	p	R228S	1	.	.	682	684	AGC	1276	1278	AGC	116;118;119	A;G;C,G	92;96;93,1	folP.WHO_M_01364c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	984	gyrA	2751	2751	100.0	gyrA.l6.c4.ctg.1	3617	81.0	1	SNP	p	S91F	0	.	.	271	273	TCC	670	672	TCC	80;80;79	T,G;C;C	65,1;65;64	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	984	gyrA	2751	2751	100.0	gyrA.l6.c4.ctg.1	3617	81.0	1	SNP	p	D95G	0	.	.	283	285	GAC	682	684	GAC	77;77;77	G;A;C	66;61;65	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	984	gyrA	2751	2751	100.0	gyrA.l6.c4.ctg.1	3617	81.0	1	SNP	p	D95N	0	.	.	283	285	GAC	682	684	GAC	77;77;77	G;A;C	66;61;65	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	27	432	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1623	79.2	1	SNP	p	G45D	0	.	.	133	135	GGC	507	509	GGC	109;109;110	G;G,T;C	90;88,1;92	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	216	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1436	45.1	0	.	n	.	0	A197.	DEL	197	197	A	846	846	A	96	A	74	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	1044	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3319	94.3	1	SNP	p	D86N	0	.	.	256	258	GAC	771	773	GAC	122;122;121	G;A,C;C	93;91,1;92	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	1044	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3319	94.3	1	SNP	p	S87I	0	.	.	259	261	AGT	774	776	AGT	121;121;122	A,C;G;T	89,2;94;90	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	1044	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3319	94.3	1	SNP	p	S87W	0	.	.	259	261	AGT	774	776	AGT	121;121;122	A,C;G;T	89,2;94;90	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	1044	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3319	94.3	1	SNP	p	S87R	0	.	.	259	261	AGT	774	776	AGT	121;121;122	A,C;G;T	89,2;94;90	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	1044	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3319	94.3	1	SNP	p	S88P	0	.	.	262	264	TCC	777	779	TCC	121;121;121	T;C;C,A	90;88;94,1	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	994	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2923	101.9	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1661	1663	GGC	127;128;127	G;G,A;C,G	104;100,1;104,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.9.001	penA.9.001	1	1	27	840	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2804	89.7	1	SNP	p	A311V	0	.	.	931	933	GCA	1484	1486	GCA	150;148;149	G,T;C;A	114,1;111;112	penA.9.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	840	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2804	89.7	1	SNP	p	I312M	0	.	.	934	936	ATC	1487	1489	ATC	150;151;151	A;T,A;C	115;107,1;115	penA.9.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	840	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2804	89.7	1	SNP	p	V316P	0	.	.	946	948	GTG	1499	1501	GTG	147;147;147	G;T;G	112;111;114	penA.9.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	840	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2804	89.7	1	SNP	p	V316T	0	.	.	946	948	GTG	1499	1501	GTG	147;147;147	G;T;G	112;111;114	penA.9.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	840	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2804	89.7	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2003	2005	ACC	109;109;110	A;C;C	87;87;93	penA.9.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	840	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2804	89.7	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2057	2059	GCG	110;107;108	G;C,A,G;G	86;85,1,1;82	penA.9.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	840	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2804	89.7	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2057	2059	GCG	110;107;108	G;C,A,G;G	86;85,1,1;82	penA.9.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	840	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2804	89.7	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2180	2182	GGC	91;90;90	G;G,T;C	77;75,1;77	penA.9.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	840	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2804	89.7	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2189	2191	GGC	87;87;87	G;G;C	73;76;75	penA.9.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	840	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2804	89.7	1	SNP	p	L552S	0	.	.	1654	1656	CTG	2207	2209	CTG	87;87;88	C;T,G;G	72;74,1;74	penA.9.001:1:1:L552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	1170	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3414	102.5	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1840	1842	CCG	99;99;99	C;C;G	76;80;76	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	548	porA	1146	1146	99.65	porA.l6.c4.ctg.1	2032	80.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	687	687	C	79	C	67	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	88	porB1a	984	295	90.3	porB1a.l15.c4.ctg.1	1390	18.2	0	.	p	.	0	H217N	NONSYN	649	651	CAT	1120	1122	AAT	9;9;9	A;A;T	7;7;7	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	88	porB1a	984	295	90.3	porB1a.l15.c4.ctg.1	1390	18.2	0	.	p	.	0	D218N	NONSYN	652	654	GAT	1123	1125	AAT	9;9;9	A;A;T	7;7;7	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	88	porB1a	984	295	90.3	porB1a.l15.c4.ctg.1	1390	18.2	0	.	p	.	0	V226A	NONSYN	676	678	GTA	1147	1149	GCA	8;8;8	G;C;A	6;7;6	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	88	porB1a	984	295	90.3	porB1a.l15.c4.ctg.1	1390	18.2	0	.	p	.	0	.	MULTIPLE	700	702	ACT	1170	1172	GTA	8;8;8	G;T;A	7;7;7	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	88	porB1a	984	295	90.3	porB1a.l15.c4.ctg.1	1390	18.2	0	.	p	.	0	S236N	NONSYN	706	708	AGC	1176	1178	AAC	8;8;8	A;A;C	6;7;7	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	88	porB1a	984	295	90.3	porB1a.l15.c4.ctg.1	1390	18.2	0	.	p	.	0	.	MULTIPLE	709	711	AAC	1180	1184	TGGCG	8;8;8;8;8	T;G;G;C;G	6;7;7;6;7	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	88	porB1a	984	295	90.3	porB1a.l15.c4.ctg.1	1390	18.2	0	.	p	.	0	D238A	NONSYN	712	714	GAT	1186	1188	GCT	8;8;8	G;C;T	7;7;6	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	88	porB1a	984	295	90.3	porB1a.l15.c4.ctg.1	1390	18.2	0	.	p	.	0	V258L	NONSYN	772	774	GTA	1246	1248	TTA	9;9;8	T;T;A	6;6;6	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	88	porB1a	984	295	90.3	porB1a.l15.c4.ctg.1	1390	18.2	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	1291	1293	CAT	8;8;8	C;A;T	6;6;6	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	88	porB1a	984	295	90.3	porB1a.l15.c4.ctg.1	1390	18.2	0	.	p	.	0	D274S	NONSYN	820	822	GAT	1294	1296	AGT	8;8;8	A;G;T	6;6;6	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	88	porB1a	984	295	90.3	porB1a.l15.c4.ctg.1	1390	18.2	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	1303	1305	TAC	8;8;8	T;A;C	6;6;6	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	730	porB1b	1047	1047	99.43	porB1b.l15.c4.ctg.1	1945	112.0	0	.	p	.	0	N38E	NONSYN	112	114	AAT	577	579	GAA	145;144;143	G;A;A	113;116;117	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	730	porB1b	1047	1047	99.43	porB1b.l15.c4.ctg.1	1945	112.0	0	.	p	.	0	N134D	NONSYN	400	402	AAT	865	867	GAT	157;158;158	G;A,C;T	120;122,1;123	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	730	porB1b	1047	1047	99.43	porB1b.l15.c4.ctg.1	1945	112.0	0	.	p	.	0	P175S	NONSYN	523	525	CCA	988	990	TCA	153;152;152	T,A;C;A,C	120,1;118;122,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	730	porB1b	1047	1047	99.43	porB1b.l15.c4.ctg.1	1945	112.0	0	.	p	.	0	A218V	NONSYN	652	654	GCC	1117	1119	GTC	166;166;167	G;T;C,A	133;130;129,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	730	porB1b	1047	1047	99.43	porB1b.l15.c4.ctg.1	1945	112.0	1	SNP	p	G120K	1	.	.	358	360	AAG	823	825	AAG	159;158;158	A;A;G	127;127;133	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	730	porB1b	1047	1047	99.43	porB1b.l15.c4.ctg.1	1945	112.0	1	SNP	p	D121N	0	.	.	361	363	GAC	826	828	GAC	159;160;161	G;A,C;C	133;131,1;128	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	730	porB1b	1047	1047	99.43	porB1b.l15.c4.ctg.1	1945	112.0	1	SNP	p	A121D	1	.	.	361	363	GAC	826	828	GAC	159;160;161	G;A,C;C	133;131,1;128	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	2208	rpoB	4179	4179	99.95	rpoB.l6.c4.ctg.1	5403	122.3	1	SNP	p	H553N	1	H553N	NONSYN	1657	1659	CAT	2286	2288	AAT	90;90;88	A;A;T	72;75;67	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	2208	rpoB	4179	4179	99.95	rpoB.l6.c4.ctg.1	5403	122.3	0	.	p	.	0	G771D	NONSYN	2311	2313	GGC	2940	2942	GAC	162;161;162	G;A,C;C	128;131,1;136	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	324	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1304	74.3	1	SNP	p	V57M	1	.	.	169	171	ATG	648	650	ATG	136;136;136	A;T;G	108;107;106	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
